Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals Małgorzata SzostakowskaAlicja Trębińska-StryjewskaAnna Fabisiewicz Review Open access 01 November 2018 Pages: 489 - 497
A systematic review of interventions to improve adherence to endocrine therapy Sue P. HeineyPearman D. ParkerJennifer M Hulett Review 01 November 2018 Pages: 499 - 510
Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer Ting LiJuan YangLujin Li Review 02 November 2018 Pages: 511 - 520
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines Britt I. DrögemöllerGalen E. B. Wrightthe CPNDS Clinical Recommendations Group Review 08 November 2018 Pages: 521 - 532
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer Ako Matsushita OharaYasuto NaoiShinzaburo Noguchi Preclinical study 25 October 2018 Pages: 533 - 543
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth Laura W. BowersClaire G. LinebergerStephen D. Hursting Preclinical study Open access 26 October 2018 Pages: 545 - 557
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention Katherine R. WalterMarvella E. FordDavid P. Turner Preclinical study Open access 27 October 2018 Pages: 559 - 571
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis Sylvie Rodrigues-FerreiraAnne NehligClara Nahmias Preclinical study 27 October 2018 Pages: 573 - 583
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer Sonia ValletFengjuan FanKlaus Podar Preclinical study 29 October 2018 Pages: 585 - 596
Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities Ethan J. HoppeLala R. HussainBarbara A. Wexelman Preclinical study 03 November 2018 Pages: 597 - 602
Treatment delays from transfers of care and their impact on breast cancer quality measures Richard J. BleicherCecilia ChangKatharine Yao Preclinical study 15 November 2018 Pages: 603 - 617
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer Cong XueWenwen WeiYanxia Shi Clinical trial 03 November 2018 Pages: 619 - 628
YouTube English videos as a source of information on breast self-examination Ebru EsenMehmet AslanRamazan Saygın Kerimoğlu Clinical trial 15 November 2018 Pages: 629 - 635
Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort Gertraud MaskarinecYurii B. ShvetsovLoïc Le Marchand Epidemiology 26 October 2018 Pages: 637 - 645
Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study Shang CaoJinyi ZhouMing Wu Epidemiology 27 October 2018 Pages: 647 - 655
Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women Tae In YoonBeom Seok KwakHee Jeong Kim Epidemiology 30 October 2018 Pages: 657 - 665
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues Yujing J. HengJun WangAndrew H. Beck Epidemiology 01 November 2018 Pages: 667 - 677
Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society Sungmin ParkByung In MoonSoo Youn Bae Epidemiology 02 November 2018 Pages: 679 - 691
Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program Abdi T. GudinaGlenn CopelandKelly A. Hirko Epidemiology 07 November 2018 Pages: 693 - 699
Survivorship care visits in a high-risk population of breast cancer survivors Sarah J. SkuliJennifer Y. ShengAntonio C. Wolff Epidemiology 07 November 2018 Pages: 701 - 708
Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women Daniela L. BuscariolloAngel M. CroninRinaa S. Punglia Epidemiology 08 November 2018 Pages: 709 - 717
Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study® Michelle I. SilverWilliam KleinMegan C. Roberts Epidemiology 09 November 2018 Pages: 719 - 726
The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer Brianna C. MortenSimon ChiuKelly A. Avery-Kiejda Epidemiology 14 November 2018 Pages: 727 - 733
Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy Young Hwan KimJi Hye HwangJoon Young Choi Brief Report 12 November 2018 Pages: 735 - 741
Trends in stage at diagnosis for young breast cancer patients in the United States Carol E. DeSantisJiemin MaAhmedin Jemal Brief Report 13 November 2018 Pages: 743 - 747
Association between pre-operative magnetic resonance imaging (MRI) and surgical outcomes in breast cancer: not yet determined Ran XuPeipei TangChunmei Li Letter to the Editor 16 November 2018 Pages: 749 - 750
Clinical implication of E-cadherin deficiency in lobular breast cancer Giovanni CorsoGabriella PravettoniPaolo Veronesi Letter to the Editor 17 November 2018 Pages: 751 - 752